During the past decade, Karmanos Cancer Institute at McLaren Greater Lansing conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 6 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Karmanos Cancer Institute at McLaren Greater Lansing" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "NRG Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karmanos Cancer Institute at McLaren Greater Lansing" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Karmanos Cancer Institute at McLaren Greater Lansing" are "Recurrent Breast Carcinoma" (4 trials), "Invasive Breast Carcinoma" (3 trials), "Stage IV Breast Cancer AJCC v6 and v7" (3 trials), "Anal Basaloid Carcinoma" (2 trials) and "Anal Canal Cloacogenic Carcinoma" (2 trials). Many other conditions were trialed in "Karmanos Cancer Institute at McLaren Greater Lansing" in a lesser frequency.

Most popular intervention types in "Karmanos Cancer Institute at McLaren Greater Lansing" are "Other" (28 trials), "Drug" (27 trials), "Radiation" (19 trials), "Biological" (18 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (18 trials), "Laboratory Biomarker Analysis" (14 trials), "Questionnaire Administration" (12 trials), "Intensity-Modulated Radiation Therapy" (9 trials) and "Fluorouracil" (8 trials). Other intervention names were less common.

The vast majority of trials in "Karmanos Cancer Institute at McLaren Greater Lansing" are 26 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Karmanos Cancer Institute at McLaren Greater Lansing". undefined are not yet recruiting, 12 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Karmanos Cancer Institute at McLaren Greater Lansing, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Karmanos Cancer Institute at McLaren Greater Lansing, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".